Australia · Delayed Price · Currency is AUD Noxopharm Statistics
Total Valuation
Noxopharm has a market cap or net worth of AUD 20.89 million. The enterprise value is 25.05 million.
| Market Cap | 20.89M |
| Enterprise Value | 25.05M |
Important Dates
The last earnings date was Monday, February 23, 2026.
| Earnings Date | Feb 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Noxopharm has 307.24 million shares outstanding. The number of shares has decreased by -0.67% in one year.
| Current Share Class | 307.24M |
| Shares Outstanding | 307.24M |
| Shares Change (YoY) | -0.67% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 28.09% |
| Owned by Institutions (%) | n/a |
| Float | 206.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.80 |
| PB Ratio | -18.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.56 |
| EV / Sales | 9.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81
| Current Ratio | 0.81 |
| Quick Ratio | 0.80 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.52 |
Financial Efficiency
Return on equity (ROE) is -343.56% and return on invested capital (ROIC) is -86.23%.
| Return on Equity (ROE) | -343.56% |
| Return on Assets (ROA) | -62.82% |
| Return on Invested Capital (ROIC) | -86.23% |
| Return on Capital Employed (ROCE) | 462.46% |
| Weighted Average Cost of Capital (WACC) | 5.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.52 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.91% in the last 52 weeks. The beta is -0.20, so Noxopharm's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -27.91% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 36.55 |
| Average Volume (20 Days) | 278,664 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Noxopharm had revenue of AUD 2.68 million and -5.49 million in losses. Loss per share was -0.02.
| Revenue | 2.68M |
| Gross Profit | -1.59M |
| Operating Income | -5.13M |
| Pretax Income | -5.49M |
| Net Income | -5.49M |
| EBITDA | -5.13M |
| EBIT | -5.13M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 91,402 in cash and 4.25 million in debt, with a net cash position of -4.15 million or -0.01 per share.
| Cash & Cash Equivalents | 91,402 |
| Total Debt | 4.25M |
| Net Cash | -4.15M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -1.13M |
| Book Value Per Share | -0.00 |
| Working Capital | -1.11M |
Cash Flow
| Operating Cash Flow | -7.27M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -59.32%, with operating and profit margins of -191.68% and -205.00%.
| Gross Margin | -59.32% |
| Operating Margin | -191.68% |
| Pretax Margin | -205.00% |
| Profit Margin | -205.00% |
| EBITDA Margin | -191.61% |
| EBIT Margin | -191.68% |
| FCF Margin | n/a |
Dividends & Yields
Noxopharm does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.67% |
| Shareholder Yield | 0.67% |
| Earnings Yield | -26.28% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |